Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Biomed Res Int ; 2013: 215283, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23555077

RESUMEN

Defence against Leishmania depends upon Th1 inflammatory response and, a major problem in susceptible models, is the turnoff of the leishmanicidal activity of macrophages with IL-10, IL-4, and COX-2 upregulation, as well as immunosuppressive PGE2, all together inhibiting the respiratory burst. Peroxisome proliferator-activated receptors (PPAR) activation is responsible for macrophages polarization on Leishmania susceptible models where microbicide functions are deactivated. In this paper, we demonstrated that, at least for L. mexicana, PPAR activation, mainly PPAR γ , induced macrophage activation through their polarization towards M1 profile with the increase of microbicide activity against intracellular pathogen L. mexicana. PPAR activation induced IL-10 downregulation, whereas the production of proinflammatory cytokines such as TNF- α , IL-1 ß , and IL-6 remained high. Moreover, PPAR agonists treatment induced the deactivation of cPLA2-COX-2-prostaglandins pathway together with an increase in TLR4 expression, all of whose criteria meet the M1 macrophage profile. Finally, parasite burden, in treated macrophages, was lower than that in infected nontreated macrophages, most probably associated with the increase of respiratory burst in these treated cells. Based on the above data, we conclude that PPAR agonists used in this work induces M1 macrophages polarization via inhibition of cPLA2 and the increase of aggressive microbicidal activity via reactive oxygen species (ROS) production.


Asunto(s)
Ciclooxigenasa 2/metabolismo , Fosfolipasas A2 Grupo IV/metabolismo , Leishmania mexicana/metabolismo , Leishmaniasis Cutánea Difusa/metabolismo , PPAR gamma/metabolismo , Animales , Células Cultivadas , Ciclooxigenasa 2/genética , Inhibidores de la Ciclooxigenasa 2/farmacología , Dinoprostona/metabolismo , Fosfolipasas A2 Grupo IV/genética , Humanos , Oxidorreductasas Intramoleculares/metabolismo , Leishmania mexicana/efectos de los fármacos , Leishmania mexicana/patogenicidad , Leishmaniasis Cutánea Difusa/genética , Leishmaniasis Cutánea Difusa/parasitología , Macrófagos/metabolismo , Ratones , PPAR gamma/agonistas , PPAR gamma/genética , Prostaglandina-E Sintasas , Especies Reactivas de Oxígeno/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...